• Friday, August 9, 2019 @ 1:00 pm

Santhera Pharmaceuticals (SIX: SANN) announces that Christoph Rentsch has decided to step down as Chief Financial Officer of Santhera by end of this year, in order to pursue his career outside the Company.

 

A search for a succession has been initiated and Christoph Rentsch will continue to support the company during the transition period.

 

Elmar Schnee, Chairman of Santhera, said: “Christoph has been a key member of the Executive Management Team over the past four years and has been instrumental in successfully delivering concepts and resources for the strategic diversification of the Company’s pipeline during that period. On behalf of the Board, I would like to thank him for his hard work and major contribution to advance Santhera’s long-term growth strategy.”

 

“I am very grateful to Christoph for his contribution to the promising development of Santhera, particularly for the successful execution of several corporate finance transactions over the past years. On behalf of the entire management team, I thank him for his valuable contributions and wish him all the best for the future,” added Thomas Meier, PhD, Chief Executive Officer of Santhera.

You may also be interested in